Takeda Pharmaceutical
TAK
#494
Rank
ยฃ35.51 B
Marketcap
ยฃ10.67
Share price
0.21%
Change (1 day)
1.30%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ3.75 Billion

According to Takeda Pharmaceutical's latest financial reports the company has ยฃ3.75 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31ยฃ2.09 B-15.28%
2024-03-31ยฃ2.47 B-26.5%
2023-03-31ยฃ3.36 B-38.48%
2022-03-31ยฃ5.46 B-16.77%
2021-03-31ยฃ6.56 B34.09%
2020-03-31ยฃ4.89 B-2.39%
2019-03-31ยฃ5.01 B99.63%
2018-03-31ยฃ2.51 B-6.74%
2017-03-31ยฃ2.69 B-22.22%
2016-03-31ยฃ3.46 B-13.54%
2015-03-31ยฃ4.00 B-18.98%
2014-03-31ยฃ4.94 B26.16%
2013-03-31ยฃ3.92 B12.87%
2012-03-31ยฃ3.47 B-46.88%
2011-03-31ยฃ6.54 B6.28%
2010-03-31ยฃ6.15 B15.72%
2009-03-31ยฃ5.31 B-35.14%
2008-03-31ยฃ8.20 B5.3%
2007-03-31ยฃ7.78 B-15.19%
2006-03-31ยฃ9.18 B22.37%
2005-03-31ยฃ7.50 B9.67%
2004-03-31ยฃ6.84 B11.3%
2003-03-31ยฃ6.14 B31.78%
2002-03-31ยฃ4.66 B15.55%
2001-03-31ยฃ4.03 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
ยฃ13.93 B 271.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ7.84 B 109.12%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
ยฃ11.25 B 199.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ7.32 B 95.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
ยฃ0.92 B-75.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
ยฃ0.59 B-84.28%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
ยฃ7.09 B 88.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ3.33 B-11.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ13.67 B 264.43%๐Ÿ‡บ๐Ÿ‡ธ USA